Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|November 1, 1992
Racial differences in patients with adenocarcinoma of the endometriumH S Cronjé, S Fourie, M J Doman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancerS J Clarke, R Abratt, L Goedhals, et al.Current Medical Research and Opinion|January 6, 2000
Phase II trial of i.v. vinorelbine and cisplatin in inoperable locally advanced or disseminated non-small-cell lung cancer: the South African experienceL Goedhals, D A Vorobiof, W Bezwoda, et al.Anti-Cancer Drugs|October 17, 1998
A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. Ondansetron Acute Emesis Study GroupM Krzakowski, E Graham, L Goedhals, et al.Oncology|January 1, 1994
Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study GroupP Ruff, W Paska, L Goedhals, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study GroupI Olver, W Paska, A Depierre, et al.Nuclear Medicine Communications|June 1, 1997
Radiation dose estimates of 186Re-hydroxyethylidene diphosphonate for palliation of metastatic osseous lesions: an animal model studyA van Aswegen, A Roodt, J Marais, et al.Oncology|May 1, 1995
Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: a multicentre, double-blind, double-dummy, randomised, parallel-group study. Emesis Study Group for Ondansetron and Granisetron in Breast Cancer PatientsA Stewart, B McQuade, J D Cronje, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2011
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancerA U Buzdar, B Xu, R Digumarti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancerD F Hayes, J A Van Zyl, A Hacking, et al.Pageof 4